Literature DB >> 29535113

Elevated platelet counts in a cohort of children with moderate-severe osteogenesis imperfecta suggest that inflammation is present.

Lois Salter1,2, Amaka C Offiah1,2, Nicholas Bishop1,2.   

Abstract

BACKGROUND: Elevated platelet counts are observed in cancer, autoimmunity and inflammation with concurrent illness. Proinflammatory cytokines are elevated in murine osteogenesis imperfecta (OI) models. We hypothesised that platelet counts might be elevated in children with moderate-severe OI.
METHODS: We reviewed the hospital records of 71 children with moderate-severe OI, treated in the Sheffield Children's Hospital's Severe, Complex and Atypical Osteogenesis Imperfecta Highly Specialised Service. Data relating platelet count (below/above average, above upper limit) to prior and concurrent events were summarised as event proportions per child. Additionally, we created platelet SD scores to assess age and time-related trends, and relationship with OI type.
RESULTS: 1206 platelet counts were recorded. Platelet SD scores were right-shifted by 0.89 SD overall. 49 of 71 (69%) patients had at least one platelet count above the normal range and 246 (20.4%) of all counts were above the upper limit of normal. Of these, 101 (41%) were high despite no confounding factors being present. For the 47 children with data at age less than 2 years, 89 (30.0%) platelet counts were above the upper limit of normal and 39 (44%) had no associated confounding factor. Elevated platelet counts were recorded most often for children with new or existing vertebral fractures.
CONCLUSIONS: Raised platelet counts were observed in association with new and healing vertebral fractures, but also (41%-44%) in the absence of identified proinflammatory factors or events. We speculate that these findings are evidence for a proinflammatory component to OI that could be a target for therapeutic intervention. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  bone disease; collagen disorders; musculo-skeletal

Mesh:

Substances:

Year:  2018        PMID: 29535113     DOI: 10.1136/archdischild-2017-313859

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Osteogenesis imperfecta and rheumatoid arthritis: connective issues.

Authors:  Laura Otilia Damian; Diana Miclea; Romana Vulturar; Alexandra Crăciun
Journal:  Osteoporos Int       Date:  2022-10       Impact factor: 5.071

Review 2.  Immunomodulatory Effects of MSCs in Bone Healing.

Authors:  Dalia Medhat; Clara I Rodríguez; Arantza Infante
Journal:  Int J Mol Sci       Date:  2019-11-02       Impact factor: 5.923

3.  RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta.

Authors:  Lidiia Zhytnik; Katre Maasalu; Ene Reimann; Aare Märtson; Sulev Kõks
Journal:  BMC Med Genomics       Date:  2020-11-23       Impact factor: 3.063

4.  The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.

Authors:  Vincent Maranda; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

5.  Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants.

Authors:  Ga Won Jeon
Journal:  Clin Exp Pediatr       Date:  2021-10-18

6.  Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta.

Authors:  In-Hong Kang; Uday K Baliga; Shilpak Chatterjee; Paramita Chakraborty; Seungho Choi; Nathan Buchweitz; Hong Li; Yongren Wu; Hai Yao; Shikhar Mehrotra; Meenal Mehrotra
Journal:  iScience       Date:  2022-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.